Welcome to our dedicated page for Nextgen Healthcare news (Ticker: NXGN), a resource for investors and traders seeking the latest updates and insights on Nextgen Healthcare stock.
NextGen Healthcare, Inc. (NXGN) provides comprehensive healthcare IT solutions that power better patient outcomes and practice efficiency. This dedicated news hub offers investors and healthcare professionals timely updates on the company's financial developments, technological innovations, and industry leadership.
Access official press releases and curated news coverage spanning NXGN's electronic health record advancements, practice management solutions, and strategic partnerships. Our collection includes updates on earnings reports, regulatory compliance milestones, product enhancements, and healthcare IT market expansion efforts.
Key areas of coverage include NXGN's role in supporting value-based care models, interoperability initiatives, and telehealth solutions development. Track the company's progress in enabling healthcare providers to meet evolving industry demands while maintaining financial sustainability.
Bookmark this page for streamlined access to verified NXGN updates. Check back regularly to stay informed about developments impacting the company's position in the competitive healthcare technology sector.
NextGen Healthcare (Nasdaq: NXGN) announces that its NextGen® Office platform has achieved ONC-Health IT certification, enabling small practices to meet the 21st Century Cures Act interoperability requirements. This certification validates the platform's compliance with essential standards for quality programs. Additionally, NextGen Office was recognized as the No. 1 Small Practice EMR/PM in the 2022 Best in KLAS Report, demonstrating its effectiveness for small practices.
DNAnexus announced the appointment of Jeff Margolis to its Board of Directors. Margolis, a veteran in healthcare technology, has extensive experience in guiding companies from startup to leadership. His role follows DNAnexus securing
NextGen Healthcare, Inc. (Nasdaq: NXGN) will release its fiscal 2023 Q2 results on Oct. 25, 2022, after market close. A conference call will follow at 5 p.m. EST. Shareholders can join by calling 800-343-5172 or 203-518-9848 for international participants, using the code NXGNQ223. An archived recording will be available for 90 days on their investor website. NextGen Healthcare offers innovative cloud-based healthcare technology solutions aimed at improving healthcare outcomes and enhancing financial performance for practices.
NextGen Healthcare (Nasdaq: NXGN) announces its 25th annual User Group Meeting (UGM) scheduled from November 6-9 at the Gaylord Opryland Resort in Nashville. This in-person event marks a return post-COVID and will feature keynote speakers such as John Nosta and Amy Purdy. Attendees will engage in over 125 breakout sessions focused on improving patient care and healthcare outcomes. The theme emphasizes better healthcare for all, in line with NextGen's commitment to innovation in healthcare technology.
NextGen Healthcare (NASDAQ:NXGN) announced that Oak Orchard Health, a federally qualified health center in Brockport, New York, has selected NextGen® Enterprise as its EHR and Practice Management solution. Serving over 30,000 patients across 12 locations, Oak Orchard aims to enhance operational efficiency and patient care using a comprehensive suite of NextGen's solutions, including NextGen Virtual Visits and Population Health. This partnership enhances NextGen's standing as a trusted provider for FQHCs, which manage nearly 40% of U.S. patient populations.
NextGen Healthcare has announced the release of its updated NextGen Behavioral Health Suite, integrating physical, dental, and behavioral health into a comprehensive EHR platform. This upgrade, beneficial for over 672,000 youth in the U.S. foster care system, includes tools to manage foster care services and state-specific reporting for compliance with regulatory requirements in states like New York and Indiana. These enhancements aim to streamline care delivery and improve community health.
NextGen Healthcare (Nasdaq: NXGN) announced its intention to apply for Qualified Health Information Network (QHIN) status under TEFCA. This move reinforces its commitment to interoperability, supporting over 100,000 providers with its electronic health records (EHR) and practice management solutions. As the first ambulatory-focused provider to seek QHIN designation, it aims to facilitate a national exchange of healthcare data once approved by the ONC. The company’s established infrastructure and existing interoperability solutions position it to enhance clinical data sharing across various healthcare systems.
NextGen Healthcare has announced enhancements to NextGen Virtual Visits, allowing group virtual appointments that include the entire care team and additional stakeholders. This improvement is a response to increased telehealth demand, with the company achieving a milestone of 3 million virtual visits since the COVID-19 pandemic began. The new features support whole-person care, enhancing patient-provider interactions and enabling behavioral health group sessions, thus expanding the application of their telehealth solutions.
NextGen Healthcare (Nasdaq: NXGN) showcases its NextGen® Office EHR at the APMA Annual Conference from July 28-31 in Orlando. This solution is the only EHR integrated with the APMA Registry, allowing podiatrists to utilize community data for better patient care. Recently, an expanded partnership with APMA enhances data analytics for podiatry. NextGen Office has been recognized as the top solution for small practices in the 2022 Best in KLAS report, focusing on improving workflows and patient outcomes.
NextGen Healthcare, Inc. (Nasdaq: NXGN) reported fiscal Q1 2023 results with total revenue of $153.3 million, marking a 5% increase from the previous year. Recurring revenue rose by 6% to $139.8 million, representing 91% of total revenue. Subscription services revenue grew by 12% to $42.8 million, reflecting strong demand. However, fully diluted earnings per share decreased to $0.02 from $0.04 year-over-year. The company revised its fiscal 2023 revenue outlook to between $621 million and $633 million, down from prior estimates.